logo

Last Update

This profile was last updated on 9/11/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Timothy Triche?

Timothy J. Triche

Director of the Center for Personalized Medicine

Children's Hospital Los Angeles

HQ Phone:  (323) 660-2450

Direct Phone: (323) ***-****direct phone

Email: t***@***.edu

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Children's Hospital Los Angeles

4650 Sunset Boulevard

Los Angeles, California,90027

United States

Company Description

Children's Hospital Los Angeles has been named the best children's hospital in California and among the top 10 in the nation for clinical excellence with its selection to the prestigious U.S. News & World Report Honor Roll. Children's Hospital is home to The S...more

Find other employees at this company (2,210)

Background Information

Employment History

Professor of Pathology and Pediatrics

USC Annenberg School for Communication & Journalism


Co-Director

USC Annenberg School for Communication & Journalism


Director of Specialized Diagnostics and Section Chief for the Laboratory of Pathology

National Cancer Institute


Professor, Pathology and Pediatrics

Daily Trojan


Professor of Pathology and Pediatrics

University of Southern California


Affiliations

GenomeDx Biosciences Inc

Board Member


Focus On Rhabdo Community

Advisory Council Member


Sanguine Corporation

Board Member


Association for Molecular Pathology

Founding Member


NanoValent Pharmaceuticals Inc

Board Member


WaferGen Bio-systems , Inc.

Member, Scientific Advisory Board


LTC Properties Inc

Director


Lifecode , Inc.

Board Member


Audi

Director, Chairman of Compensation Committee, Member


Proof Centre

Board Member


Children's Oncology Group

Founding Member


Doheny Eye Institute

Beckman Fellow of the Beckman Macular Research Center


NCI's

Standing Member of Advisory Committees for Clinical and Basic Cancer Biology Studies


Insert Therapeutics , Inc.

Advisory Boards


Calando Pharmaceuticals , Inc.

Advisory Boards


Baird Capital Partners

Advisory Boards


Real Time Genomics Inc

Scientific Board Member


IBC Life Sciences

Scientific Advisory Board Member


Novellix

Board Member


Novelix Pharmaceuticals Inc

Board Member


SV Bio

Board Member


Education

A.B.

Cornell University


BSc

Physics

Cornell University


M.D.

Keck School of Medicine


MD

Ronald A. Matricaria Institute of Molecular Medicine


MD/PhD

University of Southern California


PhD

Tulane University


PhD

University of Southern California


Web References(152 Total References)


GenomeDx Biosciences: Board of Directors

genomedx.com [cached]

Dr. Davicioni trained as a pathobiologist in the genomics laboratory of Professor Triche before becoming an entrepreneur, raising over $20M in grant funding and equity financing to launch GenomeDx.
Timothy Triche, MD, PhD Director Dr. Triche is a board-certified anatomical and molecular pathologist and academic professor of pathology and laboratory medicine. Tim has built, operated and owned high-complexity molecular diagnostics testing laboratories for the past 30 years and runs the GenomeDx clinical laboratory. Previously, he was the director of Specialized Diagnostics and Section Chief for the Laboratory of Pathology at the National Cancer Institute before becoming Pathologist-in-Chief at Children's Hospital of Los Angeles and Vice-Chair for the Department of Pathology at the Keck School of Medicine at the University of Southern California. Currently, Dr. Triche is the director of the Center for Personalized Medicine at Children's Hospital Los Angeles. He is a founding member of the Association for Molecular Pathology and has previously served as a senior executive in a number of medical companies, including founder and CEO of Oncomed Inc., which pioneered the use of hereditary genetic testing in oncology. Dr. Triche received his BSc in Physics at Cornell University, MD and PhD at Tulane University and completed his residency in anatomical pathology at Washington University School of Medicine. Tim's research in the field of applied genomics and the molecular biology of cancer has been recognized by numerous awards, grants and over 200 peer-reviewed publications. His goal in co-founding GenomeDx was to realize the promise of genomic technology towards improving the practice of cancer medicine.


Advisory Board/Council - Focus on Rhabdo

focusonrhabdo.org [cached]

Timothy J. Triche, MD, PhD - Children's Hospital of Los Angeles


NanoSmart(TM) Pharmaceuticals Joins Forces with Children's Hospital Los Angeles to Fight Pediatric Cancer | CHLA

www.chla.org [cached]

Collaborative research with Children's Hospital Los Angeles will be conducted under the guidance of Timothy Triche, MD, PhD, Professor of Pathology and Pediatrics and Director of the Children's Hospital Los Angeles Department of Pathology's Center for Personalized Medicine.
"We are pleased to work with NanoSmart as part of our ongoing research program in nanoparticle-mediated therapy of Ewing's sarcoma. This research will complement other research currently in progress in our lab. It is unique in that NanoSmart has leveraged a naturally occurring human antibody to target the nanoparticles to the tumor, which if successful should facilitate rapid approval from the FDA for use on Ewing's sarcoma patients," said Dr. Triche, "In addition to Dr. Triche's expertise and guidance, we look forward to initial characterization and testing of NanoSmart's formulations in the unique model of metastatic Ewing's Sarcoma at Children's Hospital."


Pathology and Laboratory Medicine Doctors | CHLA

www.chla.org [cached]

Timothy Triche, MD, PhD
Pathologist; Co-Director, Center for Personalized Medicine Program (CPM) Professor of Pathology and Pediatrics, USC Keck School of Medicine


Pathology and Laboratory Medicine Doctors | CHLA

www.chla.org [cached]

Timothy Triche, MD, PhD
Pathologist; Co-Director, Center for Personalized Medicine Program (CPM), Professor of Pathology and Pediatrics, USC Keck School of Medicine


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory